ACTIVE

CLINIMETRICS

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

24,4 M €

-85.2% YoY

Revenue

308,2 k €

+3.2% YoY

Equity

192,5 M €

+14.5% YoY

What does CLINIMETRICS do?

CLINIMETRICS is a Public limited company incorporated in 1985. Its main activity is: Market research and public opinion polling. Its registered office is in Uccle.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0426.756.052

Incorporation

10/01/1985

Legal form

Public limited company

Registered office

Rue de Percke 76
1180 Uccle · BruxellesSee on map

Contributed capital

62 000,00 €

Latest accounts

31/12/2025

Activities (NACE)

73200Market research and public opinion polling· main 73200Market research and public opinion polling 74131Specialised design activities

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Revenue	308,2 k €	+3.2%	298,7 k €		–		–		–		–		–		–		–		–		–		–		–		492,4 k €		–		–		–		–		–		–
EBITDA	47,4 k €	+189%	-53,1 k €	-117%	322 k €	+11.9%	287,7 k €	+35.1%	212,9 k €	-7.5%	230,2 k €	+27.2%	181 k €	+6.0%	170,8 k €	-32.3%	252,1 k €	+46.2%	172,4 k €	+554%	26,4 k €	-67.9%	82,2 k €	+557%	-18 k €	+54.0%	-39,1 k €	-166%	59,1 k €	+198%	19,8 k €	-45.3%	36,3 k €	+416%	7 k €	-82.2%	39,6 k €	+463%	7 k €
Operating result	-49,6 k €	+65.9%	-145,4 k €	-166%	221,5 k €	+14.4%	193,6 k €	+198%	-197,4 k €	-222%	162,4 k €	-3.6%	168,4 k €	+0.6%	167,4 k €	-32.7%	248,8 k €	+52.1%	163,6 k €	+818%	17,8 k €	-77.5%	79,1 k €	+384%	-27,9 k €	+41.8%	-47,8 k €	-193%	51,3 k €	+337%	11,7 k €	-58.8%	28,5 k €	+601%	4,1 k €	-89.1%	37,3 k €	+532%	5,9 k €
Net result	24,4 M €	-85.2%	165,3 M €	+14436%	1,1 M €	+604%	161,4 k €	+237%	-118,3 k €	-108%	1,4 M €	-56.7%	3,3 M €	+1704%	180,7 k €	-97.1%	6,3 M €	+3260%	188,4 k €	+1405%	12,5 k €	-96.0%	313 k €	+153%	123,5 k €	+123%	55,3 k €	+35.3%	40,9 k €	+251%	11,6 k €	-66.6%	34,8 k €	+3193%	1,1 k €	-95.4%	22,8 k €	+579%	3,4 k €
Balance sheet
Equity	192,5 M €	+14.5%	168,1 M €	+1174%	13,2 M €	+9.4%	12,1 M €	+1.4%	11,9 M €	-1.0%	12 M €	+13.3%	10,6 M €	+44.4%	7,3 M €	+2.5%	7,2 M €	+258%	2 M €	+10.4%	1,8 M €	+0.7%	1,8 M €	+21.0%	1,5 M €	+9.0%	1,4 M €	+4.2%	1,3 M €	+392%	266,3 k €	+56.7%	169,9 k €	+68.4%	100,9 k €	+1.1%	99,9 k €	+29.6%	77,1 k €
Total assets	197,7 M €	+12.8%	175,3 M €	+1027%	15,6 M €	+4.2%	14,9 M €	+3.0%	14,5 M €	+13.2%	12,8 M €	+10.3%	11,6 M €	+36.9%	8,5 M €	-3.0%	8,7 M €	+51.5%	5,8 M €	-1.5%	5,9 M €	+47.0%	4 M €	+5.6%	3,8 M €	+0.3%	3,8 M €	-8.9%	4,1 M €	+931%	400,9 k €	+28.5%	312,1 k €	+107%	150,5 k €	-5.8%	159,8 k €	-0.8%	161,1 k €
Cash	796 k €	-93.0%	11,3 M €	+324%	2,7 M €	-5.3%	2,8 M €	+132%	1,2 M €	-50.5%	2,4 M €	+28.4%	1,9 M €	+224%	587,8 k €	-42.2%	1 M €	+23006%	4,4 k €	-95.3%	94,3 k €	+1406%	6,3 k €	-58.7%	15,1 k €	-68.0%	47,3 k €	+288%	12,2 k €	-23.8%	16 k €	-67.1%	48,6 k €	+32.8%	36,6 k €	+193%	12,5 k €	+3.8%	12 k €
Debts	5,2 M €	-27.3%	7,1 M €	+207%	2,3 M €	-18.7%	2,9 M €	+10.3%	2,6 M €	+231%	784 k €	-21.3%	995,8 k €	-11.8%	1,1 M €	-28.3%	1,6 M €	-58.0%	3,7 M €	-7.2%	4 M €	+85.4%	2,2 M €	-4.6%	2,3 M €	-4.7%	2,4 M €	-15.1%	2,8 M €	+2001%	134,2 k €	+38.4%	97 k €	+139%	40,6 k €	-32.1%	59,9 k €	-28.7%	84 k €
Other
Workforce	–		–		–		–		–		–		–		–		–		–		0,7 ETP	0.0%	0,7 ETP	0.0%	0,7 ETP	-30.0%	1,0 ETP		–		–		–		–		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 28 ended

Active mandates

CYCO INVEST

Director · since 01 juillet 2025 · until 25 juin 2029 · 1023.271.806

Represented by Mathieu Buyse

Active

HETAFIN

Director · since 01 juillet 2025 · until 25 juin 2029 · 0454.892.881

Represented by Henri Tassenoy

Active

NITYA

Director · since 01 juillet 2025 · until 25 juin 2029 · 1019.934.214

Represented by Céline Buyse

Active

Marc BUYSE

Director · since 06 mai 2024 · until 25 juin 2029

Active

Ended mandates

CELINE BUYSE

Director · since 06 mai 2024 · until 24 juin 2030

Ended

Céline BUYSE

Director · since 06 mai 2024 · until 30 juin 2025

Ended

Henri TASSENOY

Director · since 06 mai 2024 · until 30 juin 2025

Ended

Henri TASSENOY

Director · since 06 mai 2024 · until 24 juin 2030

Ended

At this address

Other companies at this address

Company	CBE no.
NITYA BOYS● Active	1038.890.883

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	31/08/2026	13/08/2025	25/07/2024	06/08/2023	22/08/2022	20/07/2021
General meeting	29/06/2026	14/07/2025	15/07/2024	26/06/2023	27/06/2022	28/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

21 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	29/06/2026	31/08/2026	French	PDF
Full model	31/12/2024	14/07/2025	13/08/2025	French	PDF
Micro model	31/12/2023	15/07/2024	25/07/2024	French	PDF
Micro model	31/12/2022	26/06/2023	06/08/2023	French	PDF
Micro model	31/12/2021	27/06/2022	22/08/2022	French	PDF
Micro model	31/12/2020	28/06/2021	20/07/2021	French	PDF
Micro model	31/12/2019	22/06/2020	05/08/2020	French	PDF
Micro model	31/12/2018	24/06/2019	31/07/2019	French	PDF
Micro model	31/12/2017	25/06/2018	06/08/2018	French	PDF
Micro model	31/12/2016	26/06/2017	05/07/2017	French	PDF
Abridged model	31/12/2015	27/06/2016	27/06/2016	French	PDF
Abridged model	31/12/2014	22/06/2015	29/07/2015	French	PDF
Abridged model	31/12/2013	23/06/2014	19/08/2014	French	PDF
Abridged model	31/12/2012	24/06/2013	12/08/2013	French	PDF
Abridged model	31/12/2011	30/06/2012	27/07/2012	French	PDF
Abridged modelCorrection	31/12/2010	27/06/2011	30/08/2011	French	PDF
Abridged model	31/12/2010	27/06/2011	28/07/2011	French	PDF
Abridged model	31/12/2009	29/06/2010	09/08/2010	French	PDF
Abridged model	31/12/2008	22/06/2009	29/07/2009	French	PDF
Abridged model	31/12/2007	23/06/2008	18/07/2008	French	PDF
Abridged model	31/12/2006	25/06/2007	30/07/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 28 ended

Active mandates

CYCO INVEST

Director · since 01 juillet 2025 · until 25 juin 2029 · 1023.271.806

Represented by Mathieu Buyse

Active

HETAFIN

Director · since 01 juillet 2025 · until 25 juin 2029 · 0454.892.881

Represented by Henri Tassenoy

Active

NITYA

Director · since 01 juillet 2025 · until 25 juin 2029 · 1019.934.214

Represented by Céline Buyse

Active

Marc BUYSE

Director · since 06 mai 2024 · until 25 juin 2029

Active

Ended mandates

CELINE BUYSE

Director · since 06 mai 2024 · until 24 juin 2030

Ended

Céline BUYSE

Director · since 06 mai 2024 · until 30 juin 2025

Ended

Henri TASSENOY

Director · since 06 mai 2024 · until 30 juin 2025

Ended

Henri TASSENOY

Director · since 06 mai 2024 · until 24 juin 2030

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Registered office19/01/2026
SIEGE SOCIAL
PDF
Mandates04/09/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates13/05/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DEMISSIONS, NOMINATIONS
PDF
Mandates19/03/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates22/09/2020
DEMISSIONS, NOMINATIONS
PDF
Mandates30/11/2018
DEMISSIONS, NOMINATIONS
PDF
Mandates29/03/2016
DEMISSIONS, NOMINATIONS
PDF
Mandates18/02/2013
OBJET - DEMISSIONS, NOMINATIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202524,4 M €↓
2024
Annual accounts 2024165,3 M €↑
01/01/2024
nominationCéline BUYSE — administratrice
2023
Annual accounts 20231,1 M €↑
2022
Annual accounts 2022161,4 k €↑
2021
Annual accounts 2021-118,3 k €↓
2020
Annual accounts 20201,4 M €↓
2019
Annual accounts 20193,3 M €↑
2018
Annual accounts 2018180,7 k €↓
2017
Annual accounts 20176,3 M €↑
2016
Annual accounts 2016188,4 k €↑
2015
Annual accounts 201512,5 k €↓
2014
Annual accounts 2014313 k €↑
2013
Annual accounts 2013123,5 k €↑
2012
Annual accounts 201255,3 k €↑
2011
Annual accounts 201140,9 k €↑
2010
Annual accounts 201011,6 k €↓
2009
Annual accounts 200934,8 k €↑
2008
Annual accounts 20081,1 k €↓
2007
Annual accounts 200722,8 k €↑
2006
Annual accounts 20063,4 k €
10/01/1985
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

CLINIMETRICS

Overview

What does CLINIMETRICS do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline